Your browser doesn't support javascript.
loading
Discovery of 6-(Fluoro-(18)F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([(18)F]-MK-6240): A Positron Emission Tomography (PET) Imaging Agent for Quantification of Neurofibrillary Tangles (NFTs).
Walji, Abbas M; Hostetler, Eric D; Selnick, Harold; Zeng, Zhizhen; Miller, Patricia; Bennacef, Idriss; Salinas, Cristian; Connolly, Brett; Gantert, Liza; Holahan, Marie; O'Malley, Stacey; Purcell, Mona; Riffel, Kerry; Li, Jing; Balsells, Jaume; OBrien, Julie A; Melquist, Stacey; Soriano, Aileen; Zhang, Xiaoping; Ogawa, Aimie; Xu, Serena; Joshi, Elizabeth; Della Rocca, Joseph; Hess, Fred J; Schachter, Joel; Hesk, David; Schenk, David; Struyk, Arie; Babaoglu, Kerim; Lohith, Talakad G; Wang, Yaode; Yang, Kun; Fu, Jianmin; Evelhoch, Jeffrey L; Coleman, Paul J.
Afiliação
  • Walji AM; Discovery Chemistry, Merck & Co., Inc. , West Point Pennsylvania 19486, United States.
  • Hostetler ED; Imaging, Merck & Co., Inc. , West Point Pennsylvania 19486, United States.
  • Selnick H; Discovery Chemistry, Merck & Co., Inc. , West Point Pennsylvania 19486, United States.
  • Zeng Z; Imaging, Merck & Co., Inc. , West Point Pennsylvania 19486, United States.
  • Miller P; Imaging, Merck & Co., Inc. , West Point Pennsylvania 19486, United States.
  • Bennacef I; Imaging, Merck & Co., Inc. , West Point Pennsylvania 19486, United States.
  • Salinas C; Imaging, Merck & Co., Inc. , West Point Pennsylvania 19486, United States.
  • Connolly B; Imaging, Merck & Co., Inc. , West Point Pennsylvania 19486, United States.
  • Gantert L; Imaging, Merck & Co., Inc. , West Point Pennsylvania 19486, United States.
  • Holahan M; Imaging, Merck & Co., Inc. , West Point Pennsylvania 19486, United States.
  • O'Malley S; Imaging, Merck & Co., Inc. , West Point Pennsylvania 19486, United States.
  • Purcell M; Imaging, Merck & Co., Inc. , West Point Pennsylvania 19486, United States.
  • Riffel K; Imaging, Merck & Co., Inc. , West Point Pennsylvania 19486, United States.
  • Li J; Process Chemistry, Merck & Co., Inc. , West Point Pennsylvania 19486, United States.
  • Balsells J; Process Chemistry, Merck & Co., Inc. , West Point Pennsylvania 19486, United States.
  • OBrien JA; Pharmacology, Merck & Co., Inc. , West Point Pennsylvania 19486, United States.
  • Melquist S; Pharmacology, Merck & Co., Inc. , West Point Pennsylvania 19486, United States.
  • Soriano A; Pharmacology, Merck & Co., Inc. , Kenilworth, New Jersey 07033, United States.
  • Zhang X; Pharmacology, Merck & Co., Inc. , Kenilworth, New Jersey 07033, United States.
  • Ogawa A; Pharmacology, Merck & Co., Inc. , Kenilworth, New Jersey 07033, United States.
  • Xu S; Pharmacology, Merck & Co., Inc. , Kenilworth, New Jersey 07033, United States.
  • Joshi E; Drug Metabolism, Merck & Co., Inc. , West Point, Pennsylvania 19486, United States.
  • Della Rocca J; Discovery Pharmaceutical Sciences, Merck & Co., Inc. , West Point, Pennsylvania 19486, United States.
  • Hess FJ; Neuroscience, Merck & Co., Inc. , West Point, Pennsylvania 19486, United States.
  • Schachter J; Neuroscience, Merck & Co., Inc. , West Point, Pennsylvania 19486, United States.
  • Hesk D; Labelled Compound Synthesis, Merck & Co., Inc. , Rahway, New Jersey, 07065, United States.
  • Schenk D; Labelled Compound Synthesis, Merck & Co., Inc. , Rahway, New Jersey, 07065, United States.
  • Struyk A; Clinical Pharmacology, Merck & Co., Inc. , West Point, Pennsylvania 19486, United States.
  • Babaoglu K; Computational Chemistry, Merck & Co., Inc. , West Point, Pennsylvania 19486, United States.
  • Lohith TG; Imaging, Merck & Co., Inc. , West Point Pennsylvania 19486, United States.
  • Wang Y; Pharmaron Beijing Co., Ltd. , Beijing 100176, China.
  • Yang K; Pharmaron Beijing Co., Ltd. , Beijing 100176, China.
  • Fu J; Pharmaron Beijing Co., Ltd. , Beijing 100176, China.
  • Evelhoch JL; Imaging, Merck & Co., Inc. , West Point Pennsylvania 19486, United States.
  • Coleman PJ; Discovery Chemistry, Merck & Co., Inc. , West Point Pennsylvania 19486, United States.
J Med Chem ; 59(10): 4778-89, 2016 05 26.
Article em En | MEDLINE | ID: mdl-27088900
Neurofibrillary tangles (NFTs) made up of aggregated tau protein have been identified as the pathologic hallmark of several neurodegenerative diseases including Alzheimer's disease. In vivo detection of NFTs using PET imaging represents a unique opportunity to develop a pharmacodynamic tool to accelerate the discovery of new disease modifying therapeutics targeting tau pathology. Herein, we present the discovery of 6-(fluoro-(18)F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine, 6 ([(18)F]-MK-6240), as a novel PET tracer for detecting NFTs. 6 exhibits high specificity and selectivity for binding to NFTs, with suitable physicochemical properties and in vivo pharmacokinetics.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Emaranhados Neurofibrilares / Tomografia por Emissão de Pósitrons / Descoberta de Drogas / Imagem Molecular / Isoquinolinas Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Emaranhados Neurofibrilares / Tomografia por Emissão de Pósitrons / Descoberta de Drogas / Imagem Molecular / Isoquinolinas Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article